Central Garden & Pet (CENT)
(Delayed Data from NSDQ)
$38.68 USD
+0.14 (0.36%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $38.59 -0.09 (-0.23%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$38.68 USD
+0.14 (0.36%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $38.59 -0.09 (-0.23%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
Zacks News
Central Garden & Pet (CENT) Q2 Earnings Meet, Sales Fall Y/Y
by Zacks Equity Research
Central Garden & Pet's (CENT) second-quarter results reflect softness in the Garden segment. However, the company is taking steps to strengthen its position.
Central Garden (CENT) Matches Q2 Earnings Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of 0% and 1.28%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Funko-A (FNKO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Funko-A (FNKO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Central Garden & Pet (CENT) in Q2 Earnings?
by Zacks Equity Research
Central Garden & Pet's (CENT) second-quarter fiscal 2023 earnings results are likely to reflect softness in the Garden portfolio.
Analysts Estimate Central Garden (CENT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Central Garden (CENT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Central Garden & Pet (CENT) Updates View, Hurt by Garden Unit
by Zacks Equity Research
Central Garden & Pet's (CENT) revises EPS view for fiscal 2023. The guidance includes the impacts of macroeconomic volatility, cost inflation and changing consumer behavior.
Central Garden & Pet (CENT) Strategies on Track, Up 8.8% YTD
by Zacks Equity Research
Central Garden & Pet's (CENT) acquisition initiative constantly strengthens its portfolio. CENT is also steadily advancing its digital capabilities and focusing on marketing activities.
Why Is Central Garden (CENT) Down 5% Since Last Earnings Report?
by Zacks Equity Research
Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Central Garden & Pet (CENT) Q1 Loss Narrower Than Expected
by Zacks Equity Research
Central Garden & Pet's (CENT) Q1 results reflect softness in the garden segment and ongoing cost inflation. However, the company is taking steps to strengthen its position.
Central Garden (CENT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of 11.11% and 3.64%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
What Awaits Central Garden & Pet (CENT) in Q1 Earnings?
by Zacks Equity Research
Central Garden & Pet's (CENT) first-quarter fiscal 2023 earnings results are likely to reflect softness in the Garden portfolio.
Are Options Traders Betting on a Big Move in Central Garden & Pet (CENT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Central Garden & Pet (CENT) stock based on the movements in the options market lately.
Why Is Central Garden (CENT) Down 7.7% Since Last Earnings Report?
by Zacks Equity Research
Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Central Garden & Pet (CENT) Posts Q4 Loss, Sales Decline Y/Y
by Zacks Equity Research
Central Garden & Pet's (CENT) Q4 results reflect softness in the garden segment and ongoing cost inflation. However, the company has been taking steps to strengthen its position.
Central Garden (CENT) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of -233.33% and 2.35%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Honest (HNST) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Honest (HNST) delivered earnings and revenue surprises of -62.50% and 0.13%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Party City (PRTY) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Party City (PRTY) delivered earnings and revenue surprises of -1,290% and 2.47%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Prestige Consumer Healthcare, Central Garden & Pet, Traeger and RealReal
by Zacks Equity Research
Prestige Consumer Healthcare, Central Garden & Pet, Traeger and RealReal have been highlighted in this Industry Outlook article.
Alto Ingredients (ALTO) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alto Ingredients (ALTO) delivered earnings and revenue surprises of -866.67% and 2.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
4 Consumer Products-Discretionary Stocks to Watch Amid Industry Headwinds
by Sumit Singh
Prestige Consumer Healthcare (PBH), Central Garden & Pet (CENT), Traeger (COOK) and The RealReal (REAL) have been focusing on superior product strategy and prudent capital investments.
Here's Why You Should Hold Central Garden & Pet (CENT) Stock
by Zacks Equity Research
Central Garden & Pet's (CENT) acquisition initiative constantly strengthens its portfolio. CENT is also steadily advancing its digital capabilities and focusing on marketing activities.
Central Garden & Pet's (CENT) Buyouts & E-Commerce Fuel Sales
by Zacks Equity Research
Central Garden & Pet's (CENT) acquisition initiative constantly strengthens its portfolio. CENT is also steadily advancing its digital capabilities and focusing on marketing activities.
Why Is Central Garden (CENT) Down 9.2% Since Last Earnings Report?
by Zacks Equity Research
Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Central Garden & Pet (CENT) Beat on Earnings & Sales in Q3
by Zacks Equity Research
Central Garden & Pet's (CENT) Q3 results are affected by headwinds, including softness in the garden segment and ongoing cost inflation. However, the 'Central to Home' strategy bodes well.
Central Garden (CENT) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of 10.32% and 2.22%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?